Clinical research of pirarubicin in the prevention of bladder carcinoma: report of 77 cases

Objective: To investigate the more effective cure for the postoperative recurrence of bladder carcinoma.Methods: Seventy-seven patients were treated with tumor base injection,bladder incisional margin injection,bladder cavity and incision immersion intraoperatively,postoperation with the intravesical instillation of pirarubicin.Results: The follow-up survey was for six months-sixty months.The total recurrence rate is 28.6%,and recurrence rate of 1-5 years is showed apart as 18.2% 6.4% 1.3%,1.3% and 0.6%.Neither incision margin metastasis,nor serious complication was found.Conclusions: The pirarubicin is safe and effective for preventing the postoperative recurrence of bladder carcinoma.